The immunologic advantage of recurrent nasopharyngeal carcinoma from the viewpoint of Galectin-9/Tim-3-related changes in the tumour microenvironment

Given salvage treatment for recurrent nasopharyngeal carcinoma (NPC) remains a clinical dilemma, immunotherapy targeting NPC-specific immunosuppression may bring new hope. We analyzed the expression of CD8, CD4, Foxp3 and Tim-3 in lymphocytes, and of Galectin-9 in tumour cells between paired primary...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Tseng-Cheng, Chen, Chao-Hsien, Wang, Cheng-Ping, Lin, Pei-Hsuan, Yang, Tsung-Lin, Lou, Pei-Jen, Ko, Jenq-Yuh, Wu, Chen-Tu, Chang, Yih-Leong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583393/
https://www.ncbi.nlm.nih.gov/pubmed/28871094
http://dx.doi.org/10.1038/s41598-017-10386-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5583393/
https://www.ncbi.nlm.nih.gov/pubmed/28871094
http://dx.doi.org/10.1038/s41598-017-10386-y

Ejemplares similares